Dialysis Equipment in Illinois

Byonyks Medical Devices is a medical device manufacturer focused on next-generation peritoneal dialysis systems for home-based kidney failure treatment. The company has received FDA 510(k) clearance for its X-1 Automated Peritoneal Dialysis (APD) Cycler, positioning it among a select group of manufacturers offering FDA-cleared APD devices. Byonyks' technology platform addresses a significant clinical need: the U.S. government's initiative to transition 80% of dialysis patients to home-based or transplant therapies, representing a major paradigm shift in a $120 billion industry that has relied on 40-year-old technology. The company's next-generation peritoneal dialysis systems are engineered to preserve peritoneal membrane integrity through biocompatible, toxin-free dialysate formulations, thereby extending patients' tenure on peritoneal dialysis therapy. Key product benefits include slower decline in residual kidney function (supported by the BALANZ clinical study), elimination of acid and pro-inflammatory mediators from dialysate, reduced malnutrition and atherosclerosis risk, and lower treatment costs through cost-effective consumables and high-performance device design. Byonyks serves the home dialysis market in the United States and internationally, targeting patients with chronic kidney disease seeking improved quality of life and clinical outcomes through home-based treatment modalities.

Organ Recovery Systems, Inc. is a specialized medical device manufacturer focused on organ preservation and transportation technology for transplantation. The company is best known for developing LifePort Kidney Transporter, the first portable hypothermic machine perfusion (HMP) system introduced in 2003, which has preserved over 275,000 kidneys across more than 22 years of clinical use. ORS also manufactures LifePort Liver Transporter, designed for precision-controlled dual perfusion of hepatic artery and portal vein using hypothermic machine perfusion with redundant preservation systems for safety. The company serves organ procurement organizations (OPOs), transplant centers, and transplant professionals worldwide. Their preservation solutions include specialized physiologic solutions formulated for organ preparation, storage, transportation, and transplantation. LifePort devices are lightweight, portable systems designed to minimize tissue damage through cold perfusion while organs transit from recovery to recipient. Clinical evidence published in peer-reviewed journals, including the New England Journal of Medicine, demonstrates significantly better 1-year and 3-year graft survival rates for deceased donor kidneys preserved with LifePort technology compared to static cold storage. ORS provides comprehensive support services including 24/7 clinical expert helpline staffed by personnel with over 200 combined years in organ preservation experience, on-site and online training modules, wet labs, mobile troubleshooting applications (available in English, Portuguese, French, and Spanish), and equipment servicing. The company maintains regulatory compliance and quality management systems aligned with medical device standards. ORS operates offices in Chicago, Illinois, and Diegem, Belgium, serving transplant programs globally.

MAK Healthcare is a leading full-service provider of pre-owned and refurbished diagnostic imaging and medical equipment worldwide. With over 15 years of industry experience, the company specializes in selling, purchasing, and supplying high-quality medical imaging systems to private clinics, imaging centers, hospitals, and biomedical shops throughout the U.S. and globally. MAK Healthcare is known for integrity, expertise, and cost-effective procurement solutions, partnering with trusted manufacturers including Philips, GE Healthcare, Siemens, Hitachi, and Toshiba. The company serves as a procurement partner for ISO-certified facilities seeking reliable, affordable alternatives to new equipment without compromising on diagnostic quality.

LSL Healthcare is a certified minority-owned manufacturer and supplier of high-quality disposable medical devices, surgical procedure kits, and hospital supplies. Founded in 1985 and based in Niles, Illinois, the company brings over 40 years of expertise in designing, manufacturing, and distributing customized products to healthcare organizations across six continents and 60+ countries. LSL Healthcare specializes in infusion therapy kits (IV Start, Central Line, PICC, Dialysis Catheter), admission kits, specialty trays (laceration, surgical prep, blood collection, circumcision, enema, trach care), urological products (urine collection, catheterization), wound care (dressings, suture kits), irrigation products, patient footwear (slippers, anti-embolism stockings, fall prevention), emesis bags, and custom medical kit assembly. The company maintains ISO 9000 certification, FDA registration, and holds contracts with major GPOs including Healthcare Purchasing Group (HPG), Premier Inc., and VitaZone. LSL emphasizes personalized customer service, supply chain resilience, and OEM/private-label manufacturing for global partners. Certified National Minority Supplier of the Year and SBA 8(a) Graduate, LSL serves hospitals, clinics, and healthcare systems across North America with approximately $28.9 million in annual revenue and a 26-person team.

Physician Software Systems develops a SaaS-based clinical decision support platform for precision dosing of medications with narrow therapeutic indices, with initial focus on erythropoietic stimulating agent (ESA) management for hemodialysis patients. The proprietary, Mayo Clinic-derived platform leverages patented algorithms and physiological modeling to deliver individualized dosing recommendations, reducing hemoglobin variability, minimizing drug costs, and improving patient outcomes. The system integrates seamlessly with existing electronic medical records (EMRs) to streamline clinician workflows, reduce manual calculation burden, and provide system-wide visibility across large patient populations. PhySoft's evidence-based approach is particularly valuable for tough-to-titrate drugs requiring frequent dose adjustments and complex clinical evaluation.

Vantive is an independent healthcare company specializing in vital organ therapies, with a 70-year legacy in kidney care products and services. The company develops and markets dialysis equipment, continuous renal replacement therapy (CRRT) systems, and extracorporeal carbon dioxide removal (ECCO2R) technology for acute care settings. Vantive's product portfolio includes peritoneal dialysis systems such as HomeChoice, hemodialysis platforms, and advanced therapies like PrismaLung+ for ARDS management. The company serves chronic kidney disease patients and acute care settings through three integrated pillars: therapies (innovative medical devices for kidney and organ support), digital solutions (software platforms to optimize care quality and efficiency), and advanced services and education (clinician training and patient support programs). Vantive operates across home-based therapies, in-center dialysis, and acute care markets. The company emphasizes coordinated care ecosystems and patient-centric treatment options including home dialysis modalities. Manufacturing and R&D capabilities support clinical research and regulatory submissions. Vantive prioritizes evidence-based innovation with publications in peer-reviewed journals and presentations at major nephrology conferences. The organization serves patients, caregivers, and clinical teams with comprehensive support resources and medical information services.